Utility of NT-proBNP monitoring in prolonged coma following massive baclofen exposure
| Errataetall: |
CommentOn: Am J Cardiol. 2016 Oct 1;118(7):998-1005. - PMID 27614855 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Emergency medicine Australasia : EMA - 35(2023), 2 vom: 01. Apr., Seite 359-361 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hodgson, Sarah E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
114471-18-0 |
|---|
| Anmerkungen: |
Date Completed 21.03.2023 Date Revised 31.03.2023 published: Print-Electronic CommentOn: Am J Cardiol. 2016 Oct 1;118(7):998-1005. - PMID 27614855 Citation Status MEDLINE |
|---|
| doi: |
10.1111/1742-6723.14154 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350413177 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350413177 | ||
| 003 | DE-627 | ||
| 005 | 20231226044931.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/1742-6723.14154 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1167.xml |
| 035 | |a (DE-627)NLM350413177 | ||
| 035 | |a (NLM)36529482 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hodgson, Sarah E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Utility of NT-proBNP monitoring in prolonged coma following massive baclofen exposure |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.03.2023 | ||
| 500 | |a Date Revised 31.03.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Am J Cardiol. 2016 Oct 1;118(7):998-1005. - PMID 27614855 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a pro-brain natriuretic peptide (1-76) |2 NLM | |
| 650 | 7 | |a Baclofen |2 NLM | |
| 650 | 7 | |a H789N3FKE8 |2 NLM | |
| 650 | 7 | |a Natriuretic Peptide, Brain |2 NLM | |
| 650 | 7 | |a 114471-18-0 |2 NLM | |
| 650 | 7 | |a Peptide Fragments |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Wong, Anselm |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Emergency medicine Australasia : EMA |d 2004 |g 35(2023), 2 vom: 01. Apr., Seite 359-361 |w (DE-627)NLM149139780 |x 1742-6723 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2023 |g number:2 |g day:01 |g month:04 |g pages:359-361 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/1742-6723.14154 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2023 |e 2 |b 01 |c 04 |h 359-361 | ||